Disparities in identification of comorbid diagnoses in children with ADHD

Tanjala T. Gipson, Eboni I. Lance, Rebecca A. Albury, Maura B. Gentner, Mary L. Leppert

Research output: Contribution to journalArticle

Abstract

Aims. This study explores disparities in identification of educationally relevant comorbidities and medication prescribing practices for children with attention-deficit hyperactivity disorder (ADHD) and either comprehensive neurodevelopmental evaluations or evaluations limited by insurance to behavior management with medication. Methods. This study was a retrospective chart review of 5- to 10-year-old children with ADHD diagnosed at the initial evaluation. Data collected included demographics, rates of comorbid conditions, medication management, and educational interventions. Results. The 2 groups were similar in age, educational supports, and medication management. The group with insurance permitting comprehensive evaluations was more likely to be Caucasian, have higher parental education levels, and have more comorbid conditions identified with academic impact. Conclusions. School-aged children with ADHD are likely to receive similar educational and medication management despite differences in evaluations. However, our data suggest that children who received comprehensive evaluations had greater identification of comorbid conditions that may influence academic, behavioral, and social outcomes.

Original languageEnglish (US)
Pages (from-to)376-381
Number of pages6
JournalClinical Pediatrics
Volume54
Issue number4
DOIs
StatePublished - Apr 25 2015

Fingerprint

Attention Deficit Disorder with Hyperactivity
Insurance
Comorbidity
Demography
Education

Keywords

  • attention-deficit hyperactive disorder
  • comorbidity
  • polypharmacy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Gipson, T. T., Lance, E. I., Albury, R. A., Gentner, M. B., & Leppert, M. L. (2015). Disparities in identification of comorbid diagnoses in children with ADHD. Clinical Pediatrics, 54(4), 376-381. DOI: 10.1177/0009922814553434

Disparities in identification of comorbid diagnoses in children with ADHD. / Gipson, Tanjala T.; Lance, Eboni I.; Albury, Rebecca A.; Gentner, Maura B.; Leppert, Mary L.

In: Clinical Pediatrics, Vol. 54, No. 4, 25.04.2015, p. 376-381.

Research output: Contribution to journalArticle

Gipson, TT, Lance, EI, Albury, RA, Gentner, MB & Leppert, ML 2015, 'Disparities in identification of comorbid diagnoses in children with ADHD' Clinical Pediatrics, vol 54, no. 4, pp. 376-381. DOI: 10.1177/0009922814553434
Gipson TT, Lance EI, Albury RA, Gentner MB, Leppert ML. Disparities in identification of comorbid diagnoses in children with ADHD. Clinical Pediatrics. 2015 Apr 25;54(4):376-381. Available from, DOI: 10.1177/0009922814553434

Gipson, Tanjala T.; Lance, Eboni I.; Albury, Rebecca A.; Gentner, Maura B.; Leppert, Mary L. / Disparities in identification of comorbid diagnoses in children with ADHD.

In: Clinical Pediatrics, Vol. 54, No. 4, 25.04.2015, p. 376-381.

Research output: Contribution to journalArticle

@article{7f2b1844ea08456a8617ec11dce99c42,
title = "Disparities in identification of comorbid diagnoses in children with ADHD",
abstract = "Aims. This study explores disparities in identification of educationally relevant comorbidities and medication prescribing practices for children with attention-deficit hyperactivity disorder (ADHD) and either comprehensive neurodevelopmental evaluations or evaluations limited by insurance to behavior management with medication. Methods. This study was a retrospective chart review of 5- to 10-year-old children with ADHD diagnosed at the initial evaluation. Data collected included demographics, rates of comorbid conditions, medication management, and educational interventions. Results. The 2 groups were similar in age, educational supports, and medication management. The group with insurance permitting comprehensive evaluations was more likely to be Caucasian, have higher parental education levels, and have more comorbid conditions identified with academic impact. Conclusions. School-aged children with ADHD are likely to receive similar educational and medication management despite differences in evaluations. However, our data suggest that children who received comprehensive evaluations had greater identification of comorbid conditions that may influence academic, behavioral, and social outcomes.",
keywords = "attention-deficit hyperactive disorder, comorbidity, polypharmacy",
author = "Gipson, {Tanjala T.} and Lance, {Eboni I.} and Albury, {Rebecca A.} and Gentner, {Maura B.} and Leppert, {Mary L.}",
year = "2015",
month = "4",
doi = "10.1177/0009922814553434",
volume = "54",
pages = "376--381",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Disparities in identification of comorbid diagnoses in children with ADHD

AU - Gipson,Tanjala T.

AU - Lance,Eboni I.

AU - Albury,Rebecca A.

AU - Gentner,Maura B.

AU - Leppert,Mary L.

PY - 2015/4/25

Y1 - 2015/4/25

N2 - Aims. This study explores disparities in identification of educationally relevant comorbidities and medication prescribing practices for children with attention-deficit hyperactivity disorder (ADHD) and either comprehensive neurodevelopmental evaluations or evaluations limited by insurance to behavior management with medication. Methods. This study was a retrospective chart review of 5- to 10-year-old children with ADHD diagnosed at the initial evaluation. Data collected included demographics, rates of comorbid conditions, medication management, and educational interventions. Results. The 2 groups were similar in age, educational supports, and medication management. The group with insurance permitting comprehensive evaluations was more likely to be Caucasian, have higher parental education levels, and have more comorbid conditions identified with academic impact. Conclusions. School-aged children with ADHD are likely to receive similar educational and medication management despite differences in evaluations. However, our data suggest that children who received comprehensive evaluations had greater identification of comorbid conditions that may influence academic, behavioral, and social outcomes.

AB - Aims. This study explores disparities in identification of educationally relevant comorbidities and medication prescribing practices for children with attention-deficit hyperactivity disorder (ADHD) and either comprehensive neurodevelopmental evaluations or evaluations limited by insurance to behavior management with medication. Methods. This study was a retrospective chart review of 5- to 10-year-old children with ADHD diagnosed at the initial evaluation. Data collected included demographics, rates of comorbid conditions, medication management, and educational interventions. Results. The 2 groups were similar in age, educational supports, and medication management. The group with insurance permitting comprehensive evaluations was more likely to be Caucasian, have higher parental education levels, and have more comorbid conditions identified with academic impact. Conclusions. School-aged children with ADHD are likely to receive similar educational and medication management despite differences in evaluations. However, our data suggest that children who received comprehensive evaluations had greater identification of comorbid conditions that may influence academic, behavioral, and social outcomes.

KW - attention-deficit hyperactive disorder

KW - comorbidity

KW - polypharmacy

UR - http://www.scopus.com/inward/record.url?scp=84925624782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925624782&partnerID=8YFLogxK

U2 - 10.1177/0009922814553434

DO - 10.1177/0009922814553434

M3 - Article

VL - 54

SP - 376

EP - 381

JO - Clinical Pediatrics

T2 - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 4

ER -